BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Takeda Pharmaceutical Co. Ltd. 

1-1, Doshomachi 4-chome

Chuo-ku  Osaka  540-8645  Japan
Phone: 81-6-6204-2111 Fax: 81-6-6204-2880


SEARCH JOBS

View Clinical Trials from BioPharm Insight




 Key Statistics


Email: n/a
Ownership: Public

Web Site: Takeda Pharmaceutical Co. Ltd.
Employees:
Symbol: TKPYY
 



Industry
Pharmaceutical






 Company News
MacroGenics, Inc. (MGNX), Takeda Pharmaceutical Co. Ltd. (TKPYY) Draw Up $1.6B DART Pact 9/30/2014 6:18:31 AM
Seattle Genetics, Inc. (SGEN) And Takeda Pharmaceutical Co. Ltd. (TKPYY) Announce Positive Data From Phase 3 AETHERA Clinical Trial Of ADCETRIS® (Brentuximab Vedotin) For Consolidation In Post-Transplant Hodgkin Lymphoma 9/29/2014 11:39:13 AM
Sucampo Pharmaceuticals, Inc. (SCMP) And Takeda Pharmaceutical Co. Ltd. (TKPYY) Launch Direct-To-Consumer Advertising Campaign For AMITIZA ® (Lubiprostone) For Chronic Idiopathic Constipation 9/29/2014 10:30:40 AM
Seattle Genetics, Inc. (SGEN), Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Cancer Drug Meets Main Goal In Phase 3 Trial 9/29/2014 6:36:12 AM
BioMotiv Attracts $25 Million Investment From Takeda Pharmaceutical Co. Ltd. (TKPYY) 9/26/2014 7:36:17 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Backs Weight Loss Drug Contrave With 900 Sales Reps 9/19/2014 5:57:19 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) To Headquarter Global Oncology Unit In Crowded Cambridge 9/16/2014 9:01:30 AM
American Diabetes Association And Takeda Pharmaceutical Co. Ltd. (TKPYY) Launch ConnecT2Day™ To Encourage Better Self-Management By Patients With Type 2 Diabetes 9/9/2014 10:58:02 AM
Eli Lilly and Company (LLY), Takeda Pharmaceutical Co. Ltd. (TKPYY) Lose Bid To Overturn $9 Billion Award For Hiding Actos' Cancer Risk 8/29/2014 5:59:23 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Announces Completion Of The Post-Marketing Commitment To Submit Data To The FDA, The European Medicines Agency And The PMDA For Pioglitazone Containing Medicines Including ACTOS 8/28/2014 11:09:59 AM
12345678910...